Design and synthesis of novel C14-hydroxyl substituted triptolide derivatives as potential selective antitumor agents. 2009

Zheng Li, and Zhao-Li Zhou, and Ze-Hong Miao, and Li-Ping Lin, and Hui-Jin Feng, and Lin-Jiang Tong, and Jian Ding, and Yuan-Chao Li
Department of Medicinal Chemistry, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, PR China.

It has long been considered that the free beta hydroxyl group at C14 of triptolide (1) is essential to its potent anticancer activity. In this study, we synthesized novel derivatives of 1 with a hydroxyl group substituted by epoxy groups (4-8) or a five-membered ring (11-13). Compounds (4-8) showed significant in vitro anticancer activity although less potent than 1. Although with an alpha oxygen configuration at the C14 position, (14S)-14,21-epoxytriptolide (4) exhibited the highest potency among all these derivatives, clearly challenging the traditional viewpoint on the necessity of C14beta-hydroxyl group of compound 1. Further studies revealed that while displaying broad spectrum in vitro anticancer activity, compound 4 demonstrated prominent selective in vivo anticancer activity, particularly against human ovarian SK-OV-3 and prostate PC-3 cancers with obviously lower toxicity than 1. Noticeably, compound 4 was also highly effective against multidrug resistant cancer cells. Therefore, our study gives new insights into the structure-activity relationship of 1 and also produces a promising anticancer drug candidate with unique anticancer activities.

UI MeSH Term Description Entries
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D010616 Phenanthrenes POLYCYCLIC AROMATIC HYDROCARBONS composed of three fused BENZENE rings.
D010618 Phenanthrolines Phenanthroline
D004224 Diterpenes Twenty-carbon compounds derived from MEVALONIC ACID or deoxyxylulose phosphate. Diterpene,Diterpenes, Cembrane,Diterpenes, Labdane,Diterpenoid,Labdane Diterpene,Norditerpene,Norditerpenes,Norditerpenoid,Cembranes,Diterpenoids,Labdanes,Norditerpenoids,Cembrane Diterpenes,Diterpene, Labdane,Labdane Diterpenes
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D004852 Epoxy Compounds Organic compounds that include a cyclic ether with three ring atoms in their structure. They are commonly used as precursors for POLYMERS such as EPOXY RESINS. Epoxide,Epoxides,Epoxy Compound,Oxiranes,Compound, Epoxy,Compounds, Epoxy
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer

Related Publications

Zheng Li, and Zhao-Li Zhou, and Ze-Hong Miao, and Li-Ping Lin, and Hui-Jin Feng, and Lin-Jiang Tong, and Jian Ding, and Yuan-Chao Li
July 2007, Journal of medicinal chemistry,
Zheng Li, and Zhao-Li Zhou, and Ze-Hong Miao, and Li-Ping Lin, and Hui-Jin Feng, and Lin-Jiang Tong, and Jian Ding, and Yuan-Chao Li
July 2011, Medicinal chemistry (Shariqah (United Arab Emirates)),
Zheng Li, and Zhao-Li Zhou, and Ze-Hong Miao, and Li-Ping Lin, and Hui-Jin Feng, and Lin-Jiang Tong, and Jian Ding, and Yuan-Chao Li
September 2018, Molecules (Basel, Switzerland),
Zheng Li, and Zhao-Li Zhou, and Ze-Hong Miao, and Li-Ping Lin, and Hui-Jin Feng, and Lin-Jiang Tong, and Jian Ding, and Yuan-Chao Li
April 2014, European journal of medicinal chemistry,
Zheng Li, and Zhao-Li Zhou, and Ze-Hong Miao, and Li-Ping Lin, and Hui-Jin Feng, and Lin-Jiang Tong, and Jian Ding, and Yuan-Chao Li
January 2024, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Zheng Li, and Zhao-Li Zhou, and Ze-Hong Miao, and Li-Ping Lin, and Hui-Jin Feng, and Lin-Jiang Tong, and Jian Ding, and Yuan-Chao Li
February 2014, European journal of medicinal chemistry,
Zheng Li, and Zhao-Li Zhou, and Ze-Hong Miao, and Li-Ping Lin, and Hui-Jin Feng, and Lin-Jiang Tong, and Jian Ding, and Yuan-Chao Li
August 2002, Archives of pharmacal research,
Zheng Li, and Zhao-Li Zhou, and Ze-Hong Miao, and Li-Ping Lin, and Hui-Jin Feng, and Lin-Jiang Tong, and Jian Ding, and Yuan-Chao Li
May 2024, Bioorganic chemistry,
Zheng Li, and Zhao-Li Zhou, and Ze-Hong Miao, and Li-Ping Lin, and Hui-Jin Feng, and Lin-Jiang Tong, and Jian Ding, and Yuan-Chao Li
May 2019, Archiv der Pharmazie,
Zheng Li, and Zhao-Li Zhou, and Ze-Hong Miao, and Li-Ping Lin, and Hui-Jin Feng, and Lin-Jiang Tong, and Jian Ding, and Yuan-Chao Li
January 2019, Medicinal chemistry (Shariqah (United Arab Emirates)),
Copied contents to your clipboard!